Member Profiles

GHECon has 42 members, including 30 faculty. GHECon members represent all four schools at UCSF (Medicine, Pharmacy, Nursing, and Dentistry) and numerous departments and units (e.g., Medicine, Obstetrics and Gynecology, Surgery, Orthopedics, Ophthalmology, Institute for Global Health Sciences, Institute for Health Policy Studies, Institute for Health and Aging).

  • Kirsten Bibbins-Domingo
    Social, behavioral, & biological factors that place vulnerable groups at risk for cardiovascular disease early in life and population-wide policy level interventions to prevent disease.
  • Joelle Brown
    Risks of sexually transmitted infections, including HIV, and promote reproductive health in Africa and globally.
  • Colin Boyle
    Worked extensively in global health, business management and strategy development.
  • Ingrid Chen
    Translation of qualitative and quantitative evidence to the implementation of changes in practice and policy in the context of neglected tropical diseases.
  • Alejandra G. de Alba Campomanes
    Risk factors and predictive algorithms for the development of retinopathy of prematurity (ROP) and the cost-effectiveness of ROP screening and treatment in the US and Latin America. Policy and economic analysis of vision screening in preschool children, including cost-effectiveness studies of vision screening devices and delivery models of on-site preschool vision screening.
  • Adams Dudley
    Developing measures of quality, appropriateness, and efficiency of care; assessing the impact of strategies intended to improve performance, and financial risk adjustment.
  • Neelam Feachem
    CEO of consultancy firm designing and operating health financing and delivery systems. Clients include governments, hospitals, insurers, medical groups, international agencies and research institutions.
  • Emily Finlayson
    Evaluation of clinical and functional outcomes after major surgery in nursing home residents in the United States. Development and evaluation of new models for surgical care to optimize patient-centered outcomes after high-risk surgery in older patients.
  • Diana Greene Foster
    Quantitative models to evaluate the effectiveness of family planning policies and the effect of unintended pregnancy on women’s lives.
  • Rich Gosselin
    Health Economics of Surgical Intervention.
  • David Heller
    Development of health system interventions that strengthen primary care by jointly addressing non-communicable and infectious diseases.
  • Renee Hsia
    Healthcare costs, financing, and health services related to access to emergency care and regionalization of care.
  • James G. Kahn
    A quarter century of experience in the empirical and modeled assessment of the cost, effects, and cost-effectiveness of global health programs, and policies, with a focus in AIDS, with work in many other disease areas.
  • Dhruv Kazi
    Cardiovascular health economist interested in understanding and improving long-term clinical outcomes among patients with cardiovascular disease.
  • Jeremy D Keenan
    Research interest include (1) treatment of infectious and inflammatory eye disease, especially as they affect resource-poor settings , and (2) population screening for eye diseases such as diabetic retinopathy and glaucoma.
  • Sebastian Kevany
    Cost effectiveness of PEPFAR
  • Jennifer Lai
    Clinical outcomes research in chronic liver disease, cirrhosis, and liver transplantation. Disparities in organ allocation and distribution in liver transplantation.
  • Jim Lightwood
    Health & economic effects of tobacco smoking cessation and prevention, cost of pediatric HIV-AIDS patients, the economics of control of contagious disease in developed & less developed countries.
  • Jenny Liu
    Health systems, workforce, cost, econometrics, quality, and access.
  • Amy Lockwood
    Exploring the intersection of public and private interests in global health through the application of business principles to strategy, policy planning, operations, financial management, and communications. Skilled at developing and implementing creative, yet practical solutions based on data and analysis.
  • Elliot Marseille
    Policy and economic analysis of HIV prevention and treatment in developing countries.
  • Wendy Max
    Economic impact of tobacco. Evaluating integrated primary healthcare in Malawi. Economic impact of hurricane Katrina on primary healthcare safety net.
  • Dominic Montagu
    Implementation Science, Children/youth, marginalized groups, global health, Policy-making, Education, Social marketing, Policy advocacy, Web site, tuberculosis, malaria, diarrhea, pneumonia, safe delivery, Interdisciplinary research collaboration.
  • Saam Morshed
    Clinical outcomes research in orthopaedics and traumatology.
  • Ulrike Muench
    Healthcare workforce, health services research, nurse and nurse practitioners, cross-country/systems comparisons, inequality in the workplace, quantitative methods.
  • Ayman Naseri
    Clinical expertise primarily in cataract surgery and graduate medical education.
  • John Peabody
    Health policy and health sector reform; health services research; quality of care, measurement, and cross-system comparisons.
  • Kathryn Phillips
    Policy issues on how health care is organized, delivered, and financed in the US.
  • George Sawaya
    Cervical cancer screening with particular interest in screening older women, cost-effectiveness and cost-utility as well as new approaches to population-based screening.
  • Starley Shade
    HIV, statistical methods, causal inference, community and clinic-based interventions, quality of care, clinical practice guidelines, clinical decision making, HIV prevention, prevention with positives, health disparities.
  • Joanne Spetz
    Nursing and patient outcomes, analysis of hospital services and organization, and assessments of the effects of minimum nurse staffing regulations.
  • Leslee Subak
    Urinary incontinence in women, with particular emphasis on the effects of weight reduction on improving symptoms in obese women, and the economics and cost-effectiveness of interventions for incontinence.
  • Hai-Yen Sung
    Economics of tobacco control and policy, cost of smoking, cancer and other illnesses, cancer screening, and risk-adjusted health outcome analyses. Cost of tobacco use for developing countries.
  • Jeff Tice
    Breast Cancer Risk AssessmentMammographic Breast DensityBreast Cancer PreventionCost effectiveness modelingHealth Technology AssessmentMedical Devices.
  • Justin White
    Using incentives for behavior change, applying insights from behavioral economics, economics of tobacco use, impact evaluation.
  • Leslie Wilson
    Economic & outcome analyses of cancer and specific chronic diseases. New diagnostics, treatments, and patterns of care affect costs and outcomes. Chagas disease in blood supply